Company intelligence / Profile preview

Toxis

Leiden, South Holland, Netherlandstoxys.com ↗
Ownership
Private
Employees
~50
Development stage
Other
01

Overview

Toxys is a Dutch biotech company and contract research organization (CRO) that specializes in the development of innovative in vitro toxicity assays for the pharmaceutical, chemical, and cosmetic industries. The company's flagship technology, ToxTracker, is a unique reporter-based assay that provides mechanistic insight into the genotoxic properties of novel compounds by monitoring cellular stress responses. Beyond genotoxicity, Toxys offers specialized platforms for developmental toxicity (ReproTracker) and skin sensitization, helping clients mitigate risk early in the drug development process. By providing high-throughput, animal-free testing solutions, Toxys enables more accurate human risk assessment and supports the global shift toward New Approach Methodologies (NAMs) in toxicology.

Modalities
Small moleculeBiologicCell therapyGene therapy
Industry
Non-Drug Biotech
02

Partnerships

Charles River LaboratoriesEurofins ScientificGentronixLabcorp

Beyond the preview

Go deeper on Toxis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toxis.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call